0001104659-20-134811.txt : 20201211 0001104659-20-134811.hdr.sgml : 20201211 20201211170114 ACCESSION NUMBER: 0001104659-20-134811 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201210 FILED AS OF DATE: 20201211 DATE AS OF CHANGE: 20201211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Echelard Yann CENTRAL INDEX KEY: 0001561958 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32639 FILM NUMBER: 201384182 MAIL ADDRESS: STREET 1: C/O LFB BIOTECHNOLOGIES, S.A.S. STREET 2: 3, AVENUE DES TROPIQUES LES ULIS CITY: COURTABOEUF STATE: I0 ZIP: 91958 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TG THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: (212) 554-4484 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030310 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 4 1 tm2038329d1_4.xml OWNERSHIP DOCUMENT X0306 4 2020-12-10 0 0001001316 TG THERAPEUTICS, INC. TGTX 0001561958 Echelard Yann 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 1 0 0 0 COMMON STOCK 2020-12-10 4 S 0 30000 40.05 D 129116 D Represents the weighted average sales price. The range of prices for such transaction was $39.90 to $40.13. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. Includes shares of restricted Common Stock, which vest over various time periods. /s/ Yann Echelard 2020-12-11